Professor Geraint Rees
Dean, Faculty of Life Sciences, University College London
About this event
- Date and time Tue 26 Feb 2019 from 8:30am to 5:00pm
- Location Royal Society of Medicine
- Organised by Digital Health
Artificial Intelligence (AI) is heralded as a disruptive technology with the potential to revolutionise many industries including health and social care. But as AI systems get better at sorting data and making predictions, the role of this technology alongside existing models of healthcare remains unclear. Attendees will have the opportunity to hear the latest updates from companies like DeepMind, Ada Health and BenevolentAI.
This event will feature academics, doctors and entrepreneurs at the forefront of AI and healthcare.
Alongside exciting use-cases of AI in healthcare, the event will also explore the regulatory and ethical implications around implementing this technology into our health service, including a debate on the likely impact of AI in Primary Care.
As the promise of AI, neural networks and deep learning algorithms grows ever larger, it can be hard to keep up with the pace of technology. This event is for anyone with a desire to better understand where these innovations can provide tangible benefits, and how they might be implemented safely, ethically and effectively.
Topics include:
- The opportunities for AI in primary care
- The ethical and regulatory perspectives of AI in healthcare
- The use of AI in drug discovery
- The application of deep learning to breast cancer screening
Key speakers
Ms Eleonora Harwich
Director of Research, Reform
Dr Hugh Harvey
Clinical Director, Kheiron Medical Technologies
Dr Dominic King
Health Lead, DeepMind
Dr Matthew Fenech
Affiliate Consultant, AI in Health, Future Advocacy
Dr Jean Nehme
Co-Founder and Chief Executive Officer, Digital Surgery
Dr Keith Grimes
Clinical Innovation Director, Babylon Health
Professor Martin Marshall
Vice Chair External Affairs, Royal College of General Practitioners
Dr Ian Churcher
Vice President, Drug Discovery, BenevolentAI
Dr Adel Baluch & Dr Shubs Upadhyay
NHS General Practitioners and Clinical Leads, Ada Health
Dr Harpreet Sood
Associate Chief Clinical Information Officer, NHS England
Mr Hetan Shah
Executive Director, Royal Statistical Society
Professor Mihaela van der Schaar
John Humphrey Plummer Professor of Machine Learning, AI and Medicine, University of Cambridge
Agenda
View the programme
Registration, tea and coffee
Welcome and introduction
Dr Sandy Wright, Trainee Representative, Digital Health Section, Royal Society of Medicine
Session one
Mr Charles Lowe, Council Member, Digital Health Section, Royal Society of Medicine
What is a research hospital?
Professor Geraint Rees, Dean, Faculty of Life Sciences, University College London
The macroeconomic ethics of the AI market in healthcare
Ms Eleonora Harwich, Director of Research, Reform
How deep learning could transform NHS breast screening
Dr Hugh Harvey, Clinical Director, Kheiron Medical Technologies
Panel discussion
Professor Geraint Rees, Ms Eleonora Harwich and Dr Hugh Harvey
Tea and coffee break
Session two
Dr Michelle Tempest, Partner, Candesic
AI update from DeepMind
Dr Dominic King, Health Lead, DeepMind
Ethical and regulatory perspectives on AI in healthcare
Dr Matthew Fenech, Affiliate Consultant, AI in Health, Future Advocacy
AI in the operating theatre
Dr Jean Nehme, Co-Founder and Chief Executive Officer, Digital Surgery
Panel discussion
Dr Dominic King, Dr Matthew Fenech and Dr Jean Nehme
Lunch
Session three
Debate: Can AI improve general practice?
Dr Keith Grimes, Clinical Innovation Director, Babylon Health and Professor Martin Marshall, Vice Chair External Affairs, Royal College of General Practitioners
Artificial intelligence - From data to drugs
Dr Ian Churcher, Vice President, Drug Discovery, BenevolentAI
Tea and coffee break
Session four
Mr Alan Clarke, Immediate Past President, Digital Health Section, Royal Society of Medicine
Global healthcare challenge: Learnings and implications for AI
Dr Adel Baluch, NHS General Practitioner and Clinical Lead, Ada Health and Dr Shubs Upadhyay, NHS Urgent Care General Practitioner and Clinical Lead, Ada Health
Session five
Vivienne Parry, Head of Engagement, Genomics England
Panel Discussion - The Topol Review: Next Steps
Dr Harpreet Sood, Associate Chief Clinical Information Officer, NHS England, Mr Hetan Shah, Executive Director, Royal Statistical Society and Professor Mihaela van der Schaar, John Humphrey Plummer Professor of Machine Learning, AI and Medicine, University of Cambridge
Closing remarks
Miss Dina Radenkovic, Trainee Representative, Digital Health Section, Royal Society of Medicine
Location
Royal Society of Medicine, 1 Wimpole St, Marylebone, London, London, W1G 0AE, United Kingdom